R. Read

Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.

S. Adak, R. Tishler, P. Busse, 2001, International Journal of Radiation Oncology, Biology, Physics.

Phase II trial of docetaxel, cisplatin, fluorouracil, and leucovorin as induction for squamous cell carcinoma of the head and neck.

A. Nixon, S. Adak, R. Tishler, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two-year combination antibiotic therapy with clarithromycin, rifabutin, and clofazimine for Crohn's disease.

W. Selby, G. Radford-Smith, P. Pavli, 2007, Gastroenterology.

Phase I/II Trial of Outpatient Docetaxel, Cisplatin, 5-Fluorouracil, Leucovorin (opTPFL) as Induction for Squamous Cell Carcinoma of the Head and Neck (SCCHN)

S. Adak, R. Tishler, M. Posner, 2002, American journal of clinical oncology.